Glutazumab Biosimilar – Research Grade from ProteoGenix; catalogue PX-TA2460; research use only.
Know who made it. See the evidence. Buy through one marketplace.
The latest biotech product designed to revolutionize the field of biopharmaceutical research. This high-quality biosimilar is a powerful tool for scientists and researchers, offering a cost-effective and reliable alternative to its brand-name counterpart, Glutazumab.
Glutazumab Biosimilar – Research Grade is a monoclonal antibody that specifically targets the human epidermal growth factor receptor 2 (HER2). It binds to the HER2 protein on the surface of cancer cells, inhibiting their growth and promoting cell death. This makes it a valuable tool for studying HER2-positive cancers, including breast, gastric, and esophageal cancers.
Glutazumab Biosimilar – Research Grade has a wide range of applications in biopharmaceutical research. Its primary use is in the development and testing of new cancer treatments. By targeting HER2, it can help researchers better understand the mechanisms of HER2-positive cancers and evaluate the efficacy of potential therapies.
This biosimilar can also be used in a variety of experimental settings. It can be used to study the role of HER2 in tumor growth and metastasis, as well as to investigate the potential of HER2 as a therapeutic target in other diseases. Additionally, Glutazumab Biosimilar – Research Grade can be used in combination with other antibodies or drugs to explore potential synergistic effects.
With its high purity and consistent quality, Glutazumab Biosimilar – Research Grade is a reliable and cost-effective option for researchers looking to study HER2 and its role in cancer. Its versatility and effectiveness make it a valuable asset in any biopharmaceutical research laboratory.
In summary, Glutazumab Biosimilar – Research Grade is a cutting-edge biotech product with a clear and defined biological function – targeting HER2. Its main applications include cancer research, while its experimental use cases offer endless possibilities for further investigation. Choose Glutazumab Biosimilar – Research Grade for your next research project and unlock the potential of HER2 as a therapeutic target.
ProteoGenix catalogue number PX-TA2460. For research use only.
Target: Glutazumab Biosimilar – Research Grade; Host: Mammalian cells; Clonality: Monoclonal antibody; Expression system: Mammalian; Purity: >95% as determined by SDS-PAGE.; Buffer: 0.01M PBS pH 7.4.
Available configurations: 50ug, 100ug, 1mg.
This product is manufactured by ProteoGenix and sold through ABMIUM without relabelling.
ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.
Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.
Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.
